Publicaciones
-
Prieto C, Stam RW, Agraz-Doblas A, Ballerini P, Camós-Guijosa M, Castaño J, Marschalek R, Bursen A, Varela I, Bueno C and Menendez P.
Activated KRAS Cooperates with MLL-AF4 to Promote Extramedullary Engraftment and Migration of Cord Blood CD34(+) HSPC But Is Insufficient to Initiate Leukemia
CANCER RESEARCH . 76(8): 2478-2489. Nº de citas: 35
-
Wlodarski MW, Hirabayashi S, Pastor V, Starý J, Hasle H, Masetti R, Dworzak M, Schmugge M, van den Heuvel-Eibrink M, Ussowicz M, De Moerloose B, Català-Temprano A, Smith OP, Sedlacek P, Lankester AC, Zecca M, Bordon V, Matthes-Martin S, Abrahamsson J, Kühl JS, Sykora KW, Albert MH, Przychodzien B, Maciejewski JP, Schwarz S, Göhring G, Schlegelberger B, Cseh A, Noellke P, Yoshimi A, Locatelli F, Baumann I, Strahm B, Niemeyer CM and EWOG-MDS.
Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents
Blood . 127(11): 1387-1397. Nº de citas: 296
-
Cseh AM, Niemeyer CM, Yoshimi A, Català-Temprano A, Frühwald MC, Hasle H, van den Heuvel-Eibrink MM, Lauten M, De Moerloose B, Smith OP, Bernig T, Gruhn B, Kulozik AE, Metzler M, Olcay L, Suttorp M, Furlan I, Strahm B and Flotho C.
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group
BRITISH JOURNAL OF HAEMATOLOGY . 172(6): 930-936. Nº de citas: 28
-
Berrueco R, Alonso-Saladrigues A, Martorell-Sampol L, Català-Temprano A, Ruiz-Llobet A, Toll T, Torrebadell-Burriel M, Naudo-Lahoz M, Camós-Guijosa M and Rives-Solà S.
Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening
PEDIATRIC BLOOD & CANCER . 62(7): 1195-1201. Nº de citas: 8
-
Barneda-Zahonero B, Collazo O, Azagra A, Fernández-Duran I, Serra-Musach J, Islam AB, Vega-García N, Malatesta R, Camós-Guijosa M, Gómez A, Román-González L, Vidal A, López-Bigas N, Villanueva A, Esteller M and Parra M.
The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma
CELL DEATH & DISEASE . 6: 1635. Nº de citas: 44
-
Niemeyer CM, Loh ML, Cseh A, Cooper T, Dvorak CC, Chan R, Xicoy B, Germing U, Kojima S, Manabe A, Dworzak M, De Moerloose B, Starý J, Smith OP, Masetti R, Català-Temprano A, Bergstraesser E, Ussowicz M, Fabri O, Baruchel A, Cavé H, Zwaan M, Locatelli F, Hasle H, van den Heuvel-Eibrink MM, Flotho C and Yoshimi A.
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
HAEMATOLOGICA . 100(1): 17-22. Nº de citas: 35
-
CastilloSD, Perosanz X, Ressler AK, Ivars M, Rodriguez J, Rovira-Zurriaga C, Nola EM, Llena J, Grego-Bessa J, Roldan-Molina M, Arnau R, Martínez-Romero A, Barber-Martínez de la Torre I, Miguel Bejarano Serrano, Vicente-Villa MA, Celis-Passini V, Salvador-Hernandez H, Mora J, Marchuk DA, Baselga E and Graupera M.
Somatic uniparental disomy of PTEN in endothelial cells causes vascular malformations in patients with PTEN Hamartoma Tumor Syndrome.
CANCER DISCOVERY . : .
-
Silbert SK, Rankin AW, Hoang CN, Semchenkova A, Myers RM, Zerkalenkova E PhD, Wang HW, Kovach AE, Yuan CM, Delgado Colon D, Vasseur L, Bataller A, John S, Utley Lyons K, Friedes BD, Alonso-Saladrigues A, Abdel-Azim H, Balducci E, Aljudi A, Balsat M, Biery DN, Chamdin A, Chang BH, Cuevo RS MD, De Moerloose B, Dickens DS, Duffner UA, Duployez N, El Chaer F, Elliott MA, Escherich G, Fernandes S, Fitzjohn MR, Gahvari ZJ, Grupp SA, He RR MD, Harrison C, Hergott CB, Hsieh EM, Kim AS, Kuo DJ, Larson DP, Lee BJ, Leguay TT, Lindsley RC, Mangaonkar AA, Mezger K, Pacenta HL, Pan J, Provost MRM, Puri L, Raikar SS, Martinez AJ, Bristol IQ, Murphy KD, Reiman L, Redell MS, Reed K, Roth Guepin G, Rubinstein JD, Savasan S, Schafernak KT, McLean Stevens A, Talleur AC, Torres Carapia N, Vargaftig J, Vatsayan A, Wölfl M, Zhao L, Rives-Solà S, Fabrizio VA, Sasaki K, Aldoss I, Boissel N, Rheingold SR, Davis KL, Ghorashian S, Jacoby E, Popov A, Lamble AJ and Shah NN.
Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia.
Blood . : .